{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T19:27:27Z","timestamp":1776972447699,"version":"3.51.4"},"reference-count":96,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Immunology"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.it.2012.06.002","type":"journal-article","created":{"date-parts":[[2012,8,3]],"date-time":"2012-08-03T19:31:10Z","timestamp":1344022270000},"page":"563-570","source":"Crossref","is-referenced-by-count":53,"title":["Chromatin modifications as therapeutic targets in MLL-rearranged leukemia"],"prefix":"10.1016","volume":"33","author":[{"given":"Aniruddha J.","family":"Deshpande","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Bradner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott A.","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.it.2012.06.002_bib0005","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.cell.2007.02.005","article-title":"Chromatin modifications and their function","volume":"128","author":"Kouzarides","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.it.2012.06.002_bib0010","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrc2876","article-title":"Covalent histone modifications \u2013 miswritten, misinterpreted and mis-erased in human cancers","volume":"10","author":"Chi","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.it.2012.06.002_bib0015","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrd1698","article-title":"Azacitidine","volume":"4","author":"Issa","year":"2005","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.it.2012.06.002_bib0020","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/nrd2180","article-title":"Decitabine","volume":"5","author":"Gore","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.it.2012.06.002_bib0025","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1517\/13543784.2010.510514","article-title":"The clinical development of histone deacetylase inhibitors as targeted anticancer drugs","volume":"19","author":"Marks","year":"2010","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.it.2012.06.002_bib0030","first-page":"220","article-title":"Epigenetics in cancer: what's the future?","volume":"25","author":"Boumber","year":"2011","journal-title":"Oncology (Williston Park)"},{"key":"10.1016\/j.it.2012.06.002_bib0035","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ccr.2011.06.009","article-title":"Selective killing of mixed lineage leukemia cells by a potent small-molecule DOT1L inhibitor","volume":"20","author":"Daigle","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.it.2012.06.002_bib0040","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nature10509","article-title":"Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia","volume":"478","author":"Dawson","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.it.2012.06.002_bib0045","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nature10334","article-title":"RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia","volume":"478","author":"Zuber","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.it.2012.06.002_bib0050","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ccr.2012.03.014","article-title":"The histone demethylase KDM1A sustains the oncogenic potential of MLL-AF9 leukemia stem cells","volume":"21","author":"Harris","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.it.2012.06.002_bib0055","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1182\/blood.V96.1.24","article-title":"Biological and therapeutic aspects of infant leukemia","volume":"96","author":"Biondi","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.it.2012.06.002_bib0060","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1182\/blood-2009-04-215152","article-title":"Novel prognostic subgroups in childhood 11q23\/MLL-rearranged acute myeloid leukemia: results of an international retrospective study","volume":"114","author":"Balgobind","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.it.2012.06.002_bib0065","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/ng765","article-title":"MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia","volume":"30","author":"Armstrong","year":"2002","journal-title":"Nat. Genet."},{"key":"10.1016\/j.it.2012.06.002_bib0070","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1182\/blood-2002-10-3221","article-title":"Gene expression signatures in MLL-rearranged T-lineage and B-precursor acute leukemias: dominance of HOX dysregulation","volume":"102","author":"Ferrando","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.it.2012.06.002_bib0075","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/S1097-2765(02)00740-2","article-title":"ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation","volume":"10","author":"Nakamura","year":"2002","journal-title":"Mol. Cell"},{"key":"10.1016\/j.it.2012.06.002_bib0080","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/S1097-2765(02)00741-4","article-title":"MLL targets SET domain methyltransferase activity to Hox gene promoters","volume":"10","author":"Milne","year":"2002","journal-title":"Mol. Cell"},{"key":"10.1016\/j.it.2012.06.002_bib0085","doi-asserted-by":"crossref","first-page":"12902","DOI":"10.1073\/pnas.231473398","article-title":"COMPASS: a complex of proteins associated with a trithorax-related SET domain protein","volume":"98","author":"Miller","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.it.2012.06.002_bib0090","doi-asserted-by":"crossref","first-page":"8342","DOI":"10.1073\/pnas.1436338100","article-title":"MLL repression domain interacts with histone deacetylases, the polycomb group proteins HPC2 and BMI-1, and the corepressor C-terminal-binding protein","volume":"100","author":"Xia","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.it.2012.06.002_bib0095","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.cell.2005.04.031","article-title":"Physical association and coordinate function of the H3 K4 methyltransferase MLL1 and the H4 K16 acetyltransferase MOF","volume":"121","author":"Dou","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.it.2012.06.002_bib0100","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1128\/MCB.21.7.2249-2258.2001","article-title":"MLL and CREB bind cooperatively to the nuclear coactivator CREB-binding protein","volume":"21","author":"Ernst","year":"2001","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.it.2012.06.002_bib0105","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1038\/leu.2009.33","article-title":"New insights to the MLL recombinome of acute leukemias","volume":"23","author":"Meyer","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.it.2012.06.002_bib0110","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/ncb1642","article-title":"Protein arginine-methyltransferase-dependent oncogenesis","volume":"9","author":"Cheung","year":"2007","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.it.2012.06.002_bib0115","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/nrc2253","article-title":"MLL translocations, histone modifications and leukaemia stem-cell development","volume":"7","author":"Krivtsov","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.it.2012.06.002_bib0120","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1007\/s12185-010-0579-8","article-title":"Grist for the MLL: how do MLL oncogenic fusion proteins generate leukemia stem cells?","volume":"91","author":"Somervaille","year":"2010","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.it.2012.06.002_bib0125","doi-asserted-by":"crossref","first-page":"984","DOI":"10.3324\/haematol.2008.002436","article-title":"The molecular biology of mixed lineage leukemia","volume":"94","author":"Slany","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.it.2012.06.002_bib0130","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/hmg\/ddl444","article-title":"The mixed-lineage leukemia fusion partner AF4 stimulates RNA polymerase II transcriptional elongation and mediates coordinated chromatin remodeling","volume":"16","author":"Bitoun","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.it.2012.06.002_bib0135","doi-asserted-by":"crossref","first-page":"4445","DOI":"10.1182\/blood-2007-05-090514","article-title":"A role for the MLL fusion partner ENL in transcriptional elongation and chromatin modification","volume":"110","author":"Mueller","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.it.2012.06.002_bib0140","doi-asserted-by":"crossref","first-page":"e1000249","DOI":"10.1371\/journal.pbio.1000249","article-title":"Misguided transcriptional elongation causes mixed lineage leukemia","volume":"7","author":"Mueller","year":"2009","journal-title":"PLoS Biol."},{"key":"10.1016\/j.it.2012.06.002_bib0145","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1101\/gad.1898410","article-title":"Linking H3K79 trimethylation to Wnt signaling through a novel Dot1-containing complex (DotCom)","volume":"24","author":"Mohan","year":"2010","journal-title":"Genes Dev."},{"key":"10.1016\/j.it.2012.06.002_bib0150","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.molcel.2010.01.026","article-title":"AFF4, a component of the ELL\/P-TEFb elongation complex and a shared subunit of MLL chimeras, can link transcription elongation to leukemia","volume":"37","author":"Lin","year":"2010","journal-title":"Mol. Cell"},{"key":"10.1016\/j.it.2012.06.002_bib0155","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ccr.2009.12.040","article-title":"A higher-order complex containing AF4 and ENL family proteins with P-TEFb facilitates oncogenic and physiologic MLL-dependent transcription","volume":"17","author":"Yokoyama","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.it.2012.06.002_bib0160","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.exphem.2010.09.003","article-title":"MLL-AF9 and MLL-ENL alter the dynamic association of transcriptional regulators with genes critical for leukemia","volume":"39","author":"Monroe","year":"2011","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.it.2012.06.002_bib0165","doi-asserted-by":"crossref","first-page":"15751","DOI":"10.1073\/pnas.1111498108","article-title":"Function of leukemogenic mixed lineage leukemia 1 (MLL) fusion proteins through distinct partner protein complexes","volume":"108","author":"Biswas","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.it.2012.06.002_bib0170","doi-asserted-by":"crossref","first-page":"10234","DOI":"10.1158\/0008-5472.CAN-10-3294","article-title":"Histone H3 lysine 79 methyltransferase Dot1 is required for immortalization by MLL oncogenes","volume":"70","author":"Chang","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.it.2012.06.002_bib0175","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ccr.2009.12.034","article-title":"MLL-AF9-induced leukemogenesis requires coexpression of the wild-type Mll allele","volume":"17","author":"Thiel","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.it.2012.06.002_bib0180","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.cell.2005.09.025","article-title":"The menin tumor suppressor protein is an essential oncogenic cofactor for MLL-associated leukemogenesis","volume":"123","author":"Yokoyama","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.it.2012.06.002_bib0185","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ccr.2011.09.008","article-title":"CBX8, a polycomb group protein, is essential for MLL-AF9-induced leukemogenesis","volume":"20","author":"Tan","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.it.2012.06.002_bib0190","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.ccr.2010.04.012","article-title":"The PAF complex synergizes with MLL fusion proteins at HOX loci to promote leukemogenesis","volume":"17","author":"Muntean","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.it.2012.06.002_bib0195","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/nchembio.773","article-title":"Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemia","volume":"8","author":"Grembecka","year":"2012","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.it.2012.06.002_bib0200","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ceb.2008.04.008","article-title":"The multi-tasking P-TEFb complex","volume":"20","author":"Bres","year":"2008","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.it.2012.06.002_bib0205","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.2174\/1389557511009011058","article-title":"Flavopiridol, the first cyclin-dependent kinase inhibitor: recent advances in combination chemotherapy","volume":"10","author":"Wang","year":"2010","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.it.2012.06.002_bib0210","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2174\/138945010790711978","article-title":"CDK inhibitors: from the bench to clinical trials","volume":"11","author":"Rizzolio","year":"2010","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.it.2012.06.002_bib0215","doi-asserted-by":"crossref","first-page":"14442","DOI":"10.1073\/pnas.0703211104","article-title":"ALL1 fusion proteins induce deregulation of EphA7 and ERK phosphorylation in human acute leukemias","volume":"104","author":"Nakanishi","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.it.2012.06.002_bib0220","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/sj.leu.2404951","article-title":"MLL-AF9 and FLT3 cooperation in acute myelogenous leukemia: development of a model for rapid therapeutic assessment","volume":"22","author":"Stubbs","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.it.2012.06.002_bib0225","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/nature07284","article-title":"Glycogen synthase kinase 3 in MLL leukaemia maintenance and targeted therapy","volume":"455","author":"Wang","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.it.2012.06.002_bib0230","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1126\/science.1186624","article-title":"The Wnt\/beta-catenin pathway is required for the development of leukemia stem cells in AML","volume":"327","author":"Wang","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.it.2012.06.002_bib0235","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ccr.2010.10.032","article-title":"beta-Catenin mediates the establishment and drug resistance of MLL leukemic stem cells","volume":"18","author":"Yeung","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.it.2012.06.002_bib0240","doi-asserted-by":"crossref","first-page":"6061","DOI":"10.1182\/blood-2008-12-197061","article-title":"Therapeutic targeting of MLL","volume":"113","author":"Liedtke","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.it.2012.06.002_bib0245","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1146\/annurev-pathol-011811-132434","article-title":"The pathogenesis of mixed-lineage leukemia","volume":"7","author":"Muntean","year":"2012","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.it.2012.06.002_bib0250","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/S0960-9822(02)00901-6","article-title":"Methylation of H3-lysine 79 is mediated by a new family of HMTases without a SET domain","volume":"12","author":"Feng","year":"2002","journal-title":"Curr. Biol."},{"key":"10.1016\/j.it.2012.06.002_bib0255","doi-asserted-by":"crossref","first-page":"30421","DOI":"10.1074\/jbc.C200366200","article-title":"Disruptor of telomeric silencing-1 is a chromatin-specific histone H3 methyltransferase","volume":"277","author":"Lacoste","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.it.2012.06.002_bib0260","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0092-8674(02)00759-6","article-title":"Dot1p modulates silencing in yeast by methylation of the nucleosome core","volume":"109","author":"van Leeuwen","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.it.2012.06.002_bib0265","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1101\/gad.1001502","article-title":"Lysine methylation within the globular domain of histone H3 by Dot1 is important for telomeric silencing and Sir protein association","volume":"16","author":"Ng","year":"2002","journal-title":"Genes Dev."},{"key":"10.1016\/j.it.2012.06.002_bib0270","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cell.2005.02.020","article-title":"hDOT1L links histone methylation to leukemogenesis","volume":"121","author":"Okada","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.it.2012.06.002_bib0275","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/ncb1464","article-title":"Leukaemic transformation by CALM-AF10 involves upregulation of Hoxa5 by hDOT1L","volume":"8","author":"Okada","year":"2006","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.it.2012.06.002_bib0280","doi-asserted-by":"crossref","first-page":"5525","DOI":"10.1038\/sj.onc.1208699","article-title":"The eleven-nineteen-leukemia protein ENL connects nuclear MLL fusion partners with chromatin","volume":"24","author":"Zeisig","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.it.2012.06.002_bib0285","doi-asserted-by":"crossref","first-page":"18059","DOI":"10.1074\/jbc.M601903200","article-title":"Dot1a-AF9 complex mediates histone H3 Lys-79 hypermethylation and repression of ENaCalpha in an aldosterone-sensitive manner","volume":"281","author":"Zhang","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.it.2012.06.002_bib0290","doi-asserted-by":"crossref","first-page":"35659","DOI":"10.1074\/jbc.M109.038448","article-title":"AF17 competes with AF9 for binding to Dot1a to up-regulate transcription of epithelial Na+ channel alpha","volume":"284","author":"Reisenauer","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.it.2012.06.002_bib0295","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ccr.2008.10.001","article-title":"H3K79 methylation profiles define murine and human MLL-AF4 leukemias","volume":"14","author":"Krivtsov","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.it.2012.06.002_bib0300","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1101\/gad.1741408","article-title":"Aberrant chromatin at genes encoding stem cell regulators in human mixed-lineage leukemia","volume":"22","author":"Guenther","year":"2008","journal-title":"Genes Dev."},{"key":"10.1016\/j.it.2012.06.002_bib0305","doi-asserted-by":"crossref","first-page":"11367","DOI":"10.1158\/0008-5472.CAN-05-1041","article-title":"Leukemogenic MLL fusion proteins bind across a broad region of the Hox a9 locus, promoting transcription and multiple histone modifications","volume":"65","author":"Milne","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.it.2012.06.002_bib0310","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ccr.2011.06.010","article-title":"MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L","volume":"20","author":"Bernt","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.it.2012.06.002_bib0315","doi-asserted-by":"crossref","first-page":"6912","DOI":"10.1182\/blood-2011-02-334359","article-title":"DOT1L, the H3K79 methyltransferase, is required for MLL-AF9-mediated leukemogenesis","volume":"117","author":"Nguyen","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.it.2012.06.002_bib0320","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.1182\/blood-2010-12-327668","article-title":"Requirement for Dot1l in murine postnatal hematopoiesis and leukemogenesis by MLL translocation","volume":"117","author":"Jo","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.it.2012.06.002_bib0325","doi-asserted-by":"crossref","first-page":"10234","DOI":"10.1158\/0008-5472.CAN-10-3294","article-title":"Histone H3 lysine 79 methyltransferase Dot1 is required for immortalization by MLL oncogenes","volume":"70","author":"Chang","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.it.2012.06.002_bib0330","doi-asserted-by":"crossref","first-page":"16746","DOI":"10.1021\/ja206312b","article-title":"Selective inhibitors of histone methyltransferase DOT1L: design, synthesis, and crystallographic studies","volume":"133","author":"Yao","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.it.2012.06.002_bib0335","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.cell.2010.05.016","article-title":"Pro isomerization in MLL1 PHD3-bromo cassette connects H3K4me readout to CyP33 and HDAC-mediated repression","volume":"141","author":"Wang","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.it.2012.06.002_bib0340","doi-asserted-by":"crossref","first-page":"4690","DOI":"10.1182\/blood-2008-01-134056","article-title":"The PHD fingers of MLL block MLL fusion protein-mediated transformation","volume":"112","author":"Muntean","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.it.2012.06.002_bib0345","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/leu.2011.278","article-title":"Connectivity mapping identifies HDAC inhibitors for the treatment of t(4;11)-positive infant acute lymphoblastic leukemia","volume":"26","author":"Stumpel","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.it.2012.06.002_bib0350","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00277-010-1099-6","article-title":"MLL-aberrant leukemia: complete cytogenetic remission following treatment with a histone deacetylase inhibitor (HDACi)","volume":"90","author":"Burbury","year":"2011","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.it.2012.06.002_bib0355","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.molcel.2005.06.029","article-title":"Recruitment of P-TEFb for stimulation of transcriptional elongation by the bromodomain protein Brd4","volume":"19","author":"Yang","year":"2005","journal-title":"Mol. Cell"},{"key":"10.1016\/j.it.2012.06.002_bib0360","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1038\/sj.onc.1210852","article-title":"BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells","volume":"27","author":"French","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.it.2012.06.002_bib0365","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nature09504","article-title":"Selective inhibition of BET bromodomains","volume":"468","author":"Filippakopoulos","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.it.2012.06.002_bib0370","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1038\/nature09589","article-title":"Suppression of inflammation by a synthetic histone mimic","volume":"468","author":"Nicodeme","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.it.2012.06.002_bib0375","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.cell.2011.08.017","article-title":"BET bromodomain inhibition as a therapeutic strategy to target c-Myc","volume":"146","author":"Delmore","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.it.2012.06.002_bib0380","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.molcel.2005.06.027","article-title":"The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription","volume":"19","author":"Jang","year":"2005","journal-title":"Mol. Cell"},{"key":"10.1016\/j.it.2012.06.002_bib0385","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.cell.2011.08.008","article-title":"Identification of 67 histone marks and histone lysine crotonylation as a new type of histone modification","volume":"146","author":"Tan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.it.2012.06.002_bib0390","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ccr.2011.06.010","article-title":"MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L","volume":"20","author":"Bernt","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.it.2012.06.002_bib0395","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nature10509","article-title":"Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia","volume":"478","author":"Dawson","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.it.2012.06.002_bib0400","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.1182\/blood-2010-12-327668","article-title":"Requirement for Dot1l in murine postnatal hematopoiesis and leukemogenesis by MLL translocation","volume":"117","author":"Jo","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.it.2012.06.002_bib0405","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/cr.2011.115","article-title":"Essential role of DOT1L in maintaining normal adult hematopoiesis","volume":"21","author":"Nguyen","year":"2011","journal-title":"Cell Res."},{"key":"10.1016\/j.it.2012.06.002_bib0410","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1158\/1078-0432.CCR-10-2156","article-title":"Aberrations of EZH2 in cancer","volume":"17","author":"Chase","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.it.2012.06.002_bib0415","first-page":"158","article-title":"Cancers and the NSD family of histone lysine methyltransferases","volume":"1816","author":"Morishita","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.it.2012.06.002_bib0420","doi-asserted-by":"crossref","first-page":"158","DOI":"10.4161\/trns.2.4.16217","article-title":"An open and shut case for the role of NSD proteins as oncogenes","volume":"2","author":"Lucio-Eterovic","year":"2011","journal-title":"Transcription"},{"key":"10.1016\/j.it.2012.06.002_bib0425","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1038\/sj.onc.1207118","article-title":"p300\/CBP and cancer","volume":"23","author":"Iyer","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.it.2012.06.002_bib0430","doi-asserted-by":"crossref","first-page":"5408","DOI":"10.1038\/sj.onc.1210609","article-title":"MOZ and MORF, two large MYSTic HATs in normal and cancer stem cells","volume":"26","author":"Yang","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.it.2012.06.002_bib0435","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/ng.349","article-title":"Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer","volume":"41","author":"van Haaften","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.it.2012.06.002_bib0440","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nature09837","article-title":"Initial genome sequencing and analysis of multiple myeloma","volume":"471","author":"Chapman","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.it.2012.06.002_bib0445","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1172\/JCI45284","article-title":"Sequencing a mouse acute promyelocytic leukemia genome reveals genetic events relevant for disease progression","volume":"121","author":"Wartman","year":"2011","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.it.2012.06.002_bib0450","doi-asserted-by":"crossref","DOI":"10.1038\/leu.2012.56","article-title":"Sequencing histone-modifying enzymes identifies UTX mutations in acute lymphoblastic leukemia","author":"Mar","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.it.2012.06.002_bib0455","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/gcc.20308","article-title":"Identification of NUP98 abnormalities in acute leukemia: JARID1A (12p13) as a new partner gene","volume":"45","author":"van Zutven","year":"2006","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.it.2012.06.002_bib0460","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1182\/blood-2010-10-312736","article-title":"KDM2b\/JHDM1b, an H3K36me2-specific demethylase, is required for initiation and maintenance of acute myeloid leukemia","volume":"117","author":"He","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.it.2012.06.002_bib0465","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/nature08036","article-title":"Haematopoietic malignancies caused by dysregulation of a chromatin-binding PHD finger","volume":"459","author":"Wang","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.it.2012.06.002_bib0470","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/nature00970","article-title":"Gene silencing: trans-histone regulatory pathway in chromatin","volume":"418","author":"Briggs","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.it.2012.06.002_bib0475","doi-asserted-by":"crossref","first-page":"E636","DOI":"10.1073\/pnas.1107107108","article-title":"Human polymerase-associated factor complex (PAFc) connects the super elongation complex (SEC) to RNA polymerase II on chromatin","volume":"108","author":"He","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.it.2012.06.002_bib0480","doi-asserted-by":"crossref","first-page":"461","DOI":"10.18632\/oncotarget.181","article-title":"PAFc, a key player in MLL-rearranged leukemogenesis","volume":"1","author":"Tan","year":"2010","journal-title":"Oncotarget"}],"container-title":["Trends in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147149061200107X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147149061200107X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,12]],"date-time":"2020-07-12T08:31:13Z","timestamp":1594542673000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147149061200107X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":96,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S147149061200107X"],"URL":"https:\/\/doi.org\/10.1016\/j.it.2012.06.002","relation":{},"ISSN":["1471-4906"],"issn-type":[{"value":"1471-4906","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}